226 related articles for article (PubMed ID: 23668926)
21. Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish.
Kim SH; Kowalski ML; Carson RP; Bridges LR; Ess KC
Dis Model Mech; 2013 Jul; 6(4):925-33. PubMed ID: 23580196
[TBL] [Abstract][Full Text] [Related]
22. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.
Wander SA; Hennessy BT; Slingerland JM
J Clin Invest; 2011 Apr; 121(4):1231-41. PubMed ID: 21490404
[TBL] [Abstract][Full Text] [Related]
23. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
McCampbell AS; Mittelstadt ML; Dere R; Kim S; Zhou L; Djordjevic B; Soliman PT; Zhang Q; Wei C; Hursting SD; Lu KH; Broaddus RR; Walker CL
Curr Mol Med; 2016; 16(3):252-65. PubMed ID: 26917264
[TBL] [Abstract][Full Text] [Related]
24. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
[TBL] [Abstract][Full Text] [Related]
25. Fetal brain mTOR signaling activation in tuberous sclerosis complex.
Tsai V; Parker WE; Orlova KA; Baybis M; Chi AW; Berg BD; Birnbaum JF; Estevez J; Okochi K; Sarnat HB; Flores-Sarnat L; Aronica E; Crino PB
Cereb Cortex; 2014 Feb; 24(2):315-27. PubMed ID: 23081885
[TBL] [Abstract][Full Text] [Related]
26. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.
Avivar-Valderas A; Bobrovnikova-Marjon E; Alan Diehl J; Bardeesy N; Debnath J; Aguirre-Ghiso JA
Oncogene; 2013 Oct; 32(41):4932-40. PubMed ID: 23160380
[TBL] [Abstract][Full Text] [Related]
27. Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response.
Babcock JT; Nguyen HB; He Y; Hendricks JW; Wek RC; Quilliam LA
J Biol Chem; 2013 May; 288(22):15687-98. PubMed ID: 23612979
[TBL] [Abstract][Full Text] [Related]
28. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling.
Manning BD; Cantley LC
Biochem Soc Trans; 2003 Jun; 31(Pt 3):573-8. PubMed ID: 12773158
[TBL] [Abstract][Full Text] [Related]
29. TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1.
Plescher M; Teleman AA; Demetriades C
Sci Rep; 2015 Sep; 5():13828. PubMed ID: 26345496
[TBL] [Abstract][Full Text] [Related]
30. ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signaling.
Winter JN; Jefferson LS; Kimball SR
Am J Physiol Cell Physiol; 2011 May; 300(5):C1172-80. PubMed ID: 21289294
[TBL] [Abstract][Full Text] [Related]
31. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1.
Tripathi DN; Chowdhury R; Trudel LJ; Tee AR; Slack RS; Walker CL; Wogan GN
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E2950-7. PubMed ID: 23878245
[TBL] [Abstract][Full Text] [Related]
32. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes.
Miyazaki M; McCarthy JJ; Esser KA
FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061
[TBL] [Abstract][Full Text] [Related]
33. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.
Shackelford DB; Vasquez DS; Corbeil J; Wu S; Leblanc M; Wu CL; Vera DR; Shaw RJ
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11137-42. PubMed ID: 19541609
[TBL] [Abstract][Full Text] [Related]
34. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.
van Veelen W; Korsse SE; van de Laar L; Peppelenbosch MP
Oncogene; 2011 May; 30(20):2289-303. PubMed ID: 21258412
[TBL] [Abstract][Full Text] [Related]
35. Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.
Lai LP; Lilley BN; Sanes JR; McMahon AP
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19450-5. PubMed ID: 24218567
[TBL] [Abstract][Full Text] [Related]
36. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
[TBL] [Abstract][Full Text] [Related]
37. Targeting mTOR globally in cancer: thinking beyond rapamycin.
Shor B; Gibbons JJ; Abraham RT; Yu K
Cell Cycle; 2009 Dec; 8(23):3831-7. PubMed ID: 19901542
[TBL] [Abstract][Full Text] [Related]
38. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling.
Miyazaki M; McCarthy JJ; Fedele MJ; Esser KA
J Physiol; 2011 Apr; 589(Pt 7):1831-46. PubMed ID: 21300751
[TBL] [Abstract][Full Text] [Related]
39. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2.
Huang J; Dibble CC; Matsuzaki M; Manning BD
Mol Cell Biol; 2008 Jun; 28(12):4104-15. PubMed ID: 18411301
[TBL] [Abstract][Full Text] [Related]
40. Mind the GAP: Wnt steps onto the mTORC1 train.
Choo AY; Roux PP; Blenis J
Cell; 2006 Sep; 126(5):834-6. PubMed ID: 16959561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
